Platinum Investment Management’s Epizyme, Inc EPZM Stock Holding History

Platinum Investment Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,603,870	Closed	-$9.71M	–	139
2022 Q2	$9.71M	Hold	6,603,870	–	–	0.37%	41
2022 Q1	$7.59M	Buy	6,603,870 +3,780,934	+134%	+$6.16M	0.23%	52
2021 Q4	$7.06M	Buy	2,822,936 +919,043	+48%	+$3.61M	0.2%	55
2021 Q3	$9.75M	Buy	+1,903,893	New	+$11.6M	0.27%	44

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Platinum Investment Management's EPZM Position: Q3 2022 in Review

Platinum Investment Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 6,603,870 shares — an estimated $9.71M sold.

Platinum Investment Management first reported a position in EPZM in Q3 2021 and held it in 4 quarters. The position peaked at $9.75M in Q3 2021. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Platinum Investment Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Platinum Investment Management sold 6,603,870 Epizyme, Inc shares in Q3 2022, an estimated $9.71M.
Platinum Investment Management first reported a position in Epizyme, Inc in Q3 2021 and held it in 4 quarters.
Platinum Investment Management's Epizyme, Inc position peaked at $9.75M in Q3 2021.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Platinum Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.